Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2407-2412
Published online before print August 23, 2007, doi: 10.1161/ATVBAHA.107.151753
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/11/2407    most recent
ATVBAHA.107.151753v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogier, N.
Right arrow Articles by Desrumaux, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogier, N.
Right arrow Articles by Desrumaux, C.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2407.)
© 2007 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Cholesterol Accumulation Is Increased in Macrophages of Phospholipid Transfer Protein-Deficient Mice

Normalization by Dietary Alpha-Tocopherol Supplementation

Nicolas Ogier; Alexis Klein; Valérie Deckert; Anne Athias; Ginette Bessède; Naig Le Guern; Laurent Lagrost; Catherine Desrumaux

From INSERM U866, Centre de Recherche INSERM, IFR Santé-STIC, Faculté de Médecine, Université de Bourgogne, Dijon, France.

Correspondence to Dr Catherine Desrumaux/Dr Laurent Lagrost, INSERM U866 - Faculté de Médecine, 7, Bd Jeanne d’Arc BP 87900, 21079 DIJON Cedex, France. E-mail Catherine.Desrumaux{at}u-bourgogne.fr or Laurent.Lagrost@u-bourgogne.fr

Objective— Phospholipid transfer protein (PLTP) is a multifunctional, extracellular lipid transport protein that plays a major role in lipoprotein metabolism and atherosclerosis. Recent in vivo studies suggested that unlike systemic PLTP, macrophage-derived PLTP would be antiatherogenic. The present study aimed at characterizing the atheroprotective properties of macrophage-derived PLTP.

Methods and Results— Peritoneal macrophages were isolated from PLTP-deficient and wild-type mice and their biochemical characteristics were compared. It is shown that macrophages isolated from PLTP-deficient mice have increased basal cholesterol content and accumulate more cholesterol in the presence of LDL compared with wild-type cells. Cholesterol parameters in macrophages of PLTP-deficient mice were normalized by dietary {alpha}-tocopherol supplementation.

Conclusions— The antiatherogenic properties of macrophage-derived PLTP are related at least in part to its ability to reduce cholesterol accumulation in macrophages through changes in the {alpha}-tocopherol content and oxidative status of the cells.

Although systemic PLTP is proatherogenic, recent findings suggested that macrophage-derived PLTP could be antiatherogenic. This study shows that the reduced {alpha}-tocopherol content of isolated macrophages from PLTP-deficient mice is associated with increased cholesterol accumulation in these cells. Cholesterol parameters in the macrophages of PLTP-deficient mice were normalized by dietary supplementation with {alpha}-tocopherol.


Key Words: phospholipid transfer protein • vitamin E • tocopherol • macrophage




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. F. Oram, G. Wolfbauer, C. Tang, W. S. Davidson, and J. J. Albers
An Amphipathic Helical Region of the N-terminal Barrel of Phospholipid Transfer Protein Is Critical for ABCA1-dependent Cholesterol Efflux
J. Biol. Chem., April 25, 2008; 283(17): 11541 - 11549.
[Abstract] [Full Text] [PDF]